team member hold Masters or Doctorate degrees. To enhance our market position, they have made and will continue to make significant investments in research and development. In fact, we invest approximately 18% of net revenues every year in research and development activities even as net revenues continue to experience strong growth. POCT products and related reagents, such as rapid test, Dry biochemical analyzer, dry-type blood cell analyzer and hematology analyzer will be coming soon. They applied Electro-chemiluminescence PCT patent；Meanwhile, Electro-chemiluminescence patent has got approval in USA ,China, Japan, Korea and other countries.